Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg

A Post-Marketing Surveillance Looking At Safety And Adherence To Treatment Of Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg

The purpose of the study is to determine the long term safety of Enbrel in adults with active rheumatoid arthritis in Luxemburg. This is a post-marketing surveillance study in rheumatology practice patients. All patients initiated with Enbrel will be observed from the start of the study in Feb 2003 for a period of at least 5 years.

Inclusion Criteria:

• Have moderate to severe active rheumatoid arthritis
• Be aged of 17 years or more
• Have inadequate response to DMards
• Give written informed consent
• Physician decides to prescribe Enbrel

Exclusion Criteria:

n/a